AU5645799A - Dna sequence encoding oncofetal ferritin protein - Google Patents

Dna sequence encoding oncofetal ferritin protein

Info

Publication number
AU5645799A
AU5645799A AU56457/99A AU5645799A AU5645799A AU 5645799 A AU5645799 A AU 5645799A AU 56457/99 A AU56457/99 A AU 56457/99A AU 5645799 A AU5645799 A AU 5645799A AU 5645799 A AU5645799 A AU 5645799A
Authority
AU
Australia
Prior art keywords
sequence encoding
dna sequence
ferritin protein
encoding oncofetal
oncofetal ferritin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56457/99A
Inventor
Chaya Moroz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gardino Investment NV
Original Assignee
Gardino Investment NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gardino Investment NV filed Critical Gardino Investment NV
Publication of AU5645799A publication Critical patent/AU5645799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU56457/99A 1998-09-11 1999-09-08 Dna sequence encoding oncofetal ferritin protein Abandoned AU5645799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12618198A IL126181A0 (en) 1998-09-11 1998-09-11 Dna sequences proteins coded by them medicaments and detection methods using same
IL126181 1998-09-11
PCT/IL1999/000485 WO2000015788A2 (en) 1998-09-11 1999-09-08 Dna sequence encoding oncofetal ferritin protein

Publications (1)

Publication Number Publication Date
AU5645799A true AU5645799A (en) 2000-04-03

Family

ID=11071957

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56457/99A Abandoned AU5645799A (en) 1998-09-11 1999-09-08 Dna sequence encoding oncofetal ferritin protein

Country Status (5)

Country Link
EP (1) EP1112358A2 (en)
JP (1) JP2003512811A (en)
AU (1) AU5645799A (en)
IL (1) IL126181A0 (en)
WO (1) WO2000015788A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571678A (en) * 1981-05-15 1996-11-05 Moroz; Chaya Placental isoferritins for the prognosis and diagnosis of immunosuppression
IL62879A (en) * 1981-05-15 1985-09-29 Chaya Moroz Monoclonal antibodies,clones producing them,preparation of such antibodies and clones and cytotoxic and immunoassay using such antibodies
CA1339958C (en) * 1988-04-08 1998-07-21 Chaya Moroz Isoferritin as a marker for pathological pregnancy
JPH03145499A (en) * 1989-10-31 1991-06-20 Nippon Kosei Butsushitsu Gakujiyutsu Kiyougikai Human monocyto growth factor
JPH0731482A (en) * 1993-07-21 1995-02-03 Life Technol Kenkyusho Recombined growth factor for human monocyte, and dna sequence coding the same

Also Published As

Publication number Publication date
EP1112358A2 (en) 2001-07-04
WO2000015788A3 (en) 2000-05-25
JP2003512811A (en) 2003-04-08
WO2000015788A2 (en) 2000-03-23
IL126181A0 (en) 1999-05-09

Similar Documents

Publication Publication Date Title
AU1220001A (en) Novel proteins and polynucleotides encoding them
AU2434199A (en) Protein
AU5264498A (en) Genes encoding telomerase proteins
EP1110969A4 (en) Interleukin 18-binding protein
AU6721696A (en) Cd44-like protein
AU5372399A (en) Dna encoding a human inhibitor-of-apoptosis protein; hiap3
AU1675900A (en) Complementary dna's encoding proteins with signal peptides
AU2462399A (en) Cubilin protein, dna sequences encoding cubilin and uses thereof
AU1744900A (en) Gtpase associated proteins
AU3670395A (en) Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
AU3640397A (en) Ob protein binding protein
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
AU1535899A (en) Genes encoding frizzled-like proteins
AUPO957397A0 (en) Transporter protein
AU1255899A (en) Dna encoding phage resistance protein
AU6844596A (en) Nucleotide sequence encoding the cd33-like protein
AU4586497A (en) Calcium-integrin binding protein
AU5882998A (en) Nucleic acid sequences encoding citrate transporter proteins
AU7753700A (en) Dna encoding prost 07 polypeptide
AU1742000A (en) Dna encoding proteins that inhibit hsp70 function
AU2659600A (en) Adipose specific protein
AU5645799A (en) Dna sequence encoding oncofetal ferritin protein
AU6223399A (en) Sequence encoding cysdv coat protein
AU6692198A (en) Novel proline-rich acidic protein
AU5435699A (en) Grip, human adapter protein related to the grb2 family member

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase